Australia's most trusted
source of pharma news
Wednesday, 08 October 2025
Posted 8 October 2025 AM
Medicines Australia has announced Recordati Rare Diseases as a new Class 2 Member of the industry organisation.
The Italian head-quartered pharma has been scaling up its Australian operations since 2023 when it announced the appointment of former Novartis executive, Guillaume Pfeiffer, as General Manager.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.